Zebra Technologies Corporation · ZBRA · FY2024 Q3 · Calendar Q4 2024
Zebra raises outlook as Q3 growth accelerates, but deployment visibility remains limited
Zebra's reported Q3 growth, expanding profitability and higher outlook support a constructive near-term operating picture. Whether that momentum can continue depends in part on the timing of large customer deployments and a broader recovery in manufacturing.
Research this report with FN2. Free to start; review your question before sending.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about ZBRA FY2024 Q3
Choose a question to continue your researchFree to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.
Transcript intelligence
What changed
Compared with the prior quarter's flat sales and raised full-year outlook, management's Q3 analysis describes a sharp acceleration in sales, broader regional growth and another outlook increase. Manufacturing remained a lagging end market, and management continued to flag limited visibility into large deployments.
Guidance delta
Management raised its full-year outlook and projected Q4 sales growth of 28–31%, with a full-year free-cash-flow target of at least $850 million.
Key takeaways
- The analysis reports Q3 sales growth of 31% and an adjusted EBITDA margin of 21.4%.
- Management described double-digit growth across regions, with strength in retail and logistics.
- AI-enabled mobile devices, generative AI features, RFID and machine vision are among the product-development priorities described.
- Manufacturing softness and uncertain large-project timing temper the growth picture.
Management priorities
- Advance AI-enabled mobile computing and generative AI features.
- Expand RFID applications and machine-vision offerings.
- Pursue disciplined investment and adjacent, synergistic acquisitions.
Follow ZBRA with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 22, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Nov 4, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Nov 4, 2026 |
| BNP Paribas | Outperform | Outperform | Maintain | Nov 4, 2026 |
| Barclays | Overweight | Overweight | Maintain | Nov 4, 2026 |
| Truist Securities | Hold | Hold | Maintain | Oct 5, 2026 |
| Needham | Buy | Buy | Maintain | Sep 15, 2026 |
| TD Cowen | Buy | Buy | Maintain | Aug 5, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Aug 5, 2026 |
| Baird | Outperform | Outperform | Maintain | May 13, 2026 |
| UBS | Buy | Buy | Maintain | Apr 30, 2025 |
| Stephens & Co. | Overweight | Overweight | Maintain | Aug 2, 2024 |
| Exane BNP Paribas | Neutral | Underperform | Upgrade | Jun 13, 2024 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Apr 8, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Aug 2, 2023 |
| JP Morgan | Overweight | Neutral | Upgrade | Apr 4, 2022 |
| Northcoast Research | Buy | Neutral | Upgrade | Mar 23, 2021 |
| Imperial Capital | Outperform | Outperform | Maintain | Nov 20, 2019 |
| Atlantic Equities | Overweight | Overweight | Maintain | Aug 27, 2019 |
| Berenberg | Buy | Buy | Maintain | Mar 7, 2019 |
| Wells Fargo | Market Perform | Market Perform | Maintain | Feb 27, 2018 |
| Wellington Shields | Buy | Hold | Upgrade | Nov 8, 2017 |
| CLSA | Buy | Buy | Maintain | Aug 3, 2016 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jun 8, 2016 |
| Avondale Partners | Perform | Market Perform | Maintain | Mar 28, 2016 |
| Oppenheimer | Outperform | Outperform | Maintain | Jan 20, 2016 |
| Barrington Research | Outperform | Outperform | Maintain | Aug 26, 2015 |
| Sidoti & Co. | Neutral | Buy | Downgrade | Jan 28, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $301.53. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Jefferies | Dushyant Ailani | $382 | $321.38 | +26.7% | Nov 11, 2026 |
| Morgan Stanley | Meta Marshall | $380 | $329.5 | +26.0% | Nov 4, 2026 |
| Truist Financial | Jamie Cook | $378 | $374.64 | +25.4% | Oct 5, 2026 |
| Needham | Robert Jamieson | $435 | $351.81 | +44.3% | Sep 15, 2026 |
| Truist Financial | Analyst unavailable | $355 | $373.87 | +17.7% | Aug 5, 2026 |
| Morgan Stanley | Meta Marshall | $360 | $373.76 | +19.4% | Aug 5, 2026 |
| KeyBanc | Analyst unavailable | $430 | $368.83 | +42.6% | Aug 5, 2026 |
| Barclays | Analyst unavailable | $410 | $368.83 | +36.0% | Aug 5, 2026 |
| Wolfe Research | Analyst unavailable | $317 | $271 | +5.1% | Jul 9, 2026 |
| Truist Financial | Analyst unavailable | $296 | $267.85 | -1.8% | Jul 2, 2026 |
| Barclays | Analyst unavailable | $346 | $245.69 | +14.7% | Jun 23, 2026 |
| Barclays | Guy Hardwick | $345 | $241.79 | +14.4% | May 13, 2026 |
| KeyBanc | Analyst unavailable | $305 | $241.79 | +1.2% | May 13, 2026 |
| Robert W. Baird | Analyst unavailable | $310 | $241.79 | +2.8% | May 13, 2026 |
| Truist Financial | Jamie Cook | $256 | $236.14 | -15.1% | Apr 20, 2026 |
| UBS | Damian Karas | $335 | $268.88 | +11.1% | Feb 13, 2026 |
| Barclays | Analyst unavailable | $330 | $274.15 | +9.4% | Feb 13, 2026 |
| Morgan Stanley | Meta Marshall | $323 | $274.15 | +7.1% | Feb 12, 2026 |
| Barclays | Guy Hardwick | $351 | $241.08 | +16.4% | Feb 6, 2026 |
| Barclays | Guy Hardwick | $368 | $259.48 | +22.0% | Jan 12, 2026 |
| Truist Financial | Jamie Cook | $291 | $254.22 | -3.5% | Dec 18, 2025 |
| Truist Financial | Analyst unavailable | $331 | $275.96 | +9.8% | Oct 29, 2025 |
| Barclays | Analyst unavailable | $360 | $274.31 | +19.4% | Oct 29, 2025 |
| Truist Financial | Analyst unavailable | $350 | $296.64 | +16.1% | Oct 8, 2025 |
| Barclays | Analyst unavailable | $375 | $296.64 | +24.4% | Oct 7, 2025 |
| Barclays | Tim Long | $301 | $302.6 | -0.2% | Aug 5, 2025 |
| UBS | Damian Karas | $425 | $318.36 | +40.9% | Feb 18, 2025 |
| Robert W. Baird | Analyst unavailable | $380 | $331.08 | +26.0% | Feb 18, 2025 |
| Truist Financial | Jamie Cook | $383 | $384.68 | +27.0% | Oct 29, 2024 |
| Robert W. Baird | Richard Eastman | $375 | $348.12 | +24.4% | Jul 31, 2024 |
| Truist Financial | Jamie Cook | $345 | $348.12 | +14.4% | Jul 31, 2024 |
| BNP Paribas | Andrew Buscaglia | $305 | $304.56 | +1.2% | Jun 13, 2024 |
| Needham | James Ricchiuti | $370 | $323.87 | +22.7% | May 16, 2024 |
| Robert W. Baird | Richard Eastman | $330 | $314.56 | +9.4% | May 1, 2024 |
| Stephens | Tommy Moll | $380 | $314.56 | +26.0% | May 1, 2024 |
| Wolfe Research | Brad Hewitt | $337 | $290.38 | +11.8% | Apr 8, 2024 |
| Truist Financial | Jamie Cook | $300 | $284.5 | -0.5% | Mar 13, 2024 |
| Needham | James Ricchiuti | $255 | $196.82 | -15.4% | Nov 1, 2023 |
| Morgan Stanley | Analyst unavailable | $260 | $270.82 | -13.8% | Dec 13, 2022 |
| Credit Suisse | Analyst unavailable | $319 | $258.1 | +5.8% | Dec 13, 2022 |
| UBS | Analyst unavailable | $495 | $325.44 | +64.2% | Aug 4, 2022 |
| Stephens | Analyst unavailable | $500 | $323.32 | +65.8% | Aug 3, 2022 |
| Needham | Analyst unavailable | $450 | $323.32 | +49.2% | Aug 3, 2022 |
| Needham | Analyst unavailable | $500 | $368.14 | +65.8% | May 4, 2022 |
| Morgan Stanley | Meta Marshall | $400 | $393.68 | +32.7% | Apr 16, 2022 |
| Wolfe Research | Brian Lau | $469 | $437.18 | +55.5% | Mar 20, 2022 |
| Needham | James Ricchiuti | $535 | $388.79 | +77.4% | Mar 10, 2022 |
Track every rating change on ZBRA the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationZebra Technologies Corporation, alongside its affiliated entities, delivers enterprise asset intelligence solutions globally within the automatic identification and data capture (AIDC) sector. Operating through its Asset Intelligence & Tracking and Enterprise Visibility & Mobility segments, the company provides a comprehensive suite of products and services. Its hardware lineup includes specialized printers for generating labels, wristbands, tickets, receipts, and plastic cards, alongside advanced dye-sublimation thermal card printers for secure identification and financial transactions, and RFID printers for data encoding. Complementing these are various accessories and essential consumables such as thermal labels, ribbons, RFID tags, and critical temperature-monitoring labels, notably used in vaccine distribution.…
Historical context
All ZBRA earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| BSP Bending Spoons S.p.A. | FY2026 Q3 · Calendar Q4 2026 | — | +6.2% | Bending Spoons raises 2026 outlook as acquisitions and AI productivity lift Q3 |
| INTU Intuit Inc. | FY2027 Q1 · Calendar Q4 2026 | +18.3% | -6.2% | Intuit's Q1 growth held up, while Credit Karma remains a drag |
| ESTC Elastic N.V. | FY2027 Q2 · Calendar Q4 2026 | +16.2% | +2.0% | Elastic accelerates growth and raises outlook as AI offerings expand |
| KEYS Keysight Technologies, Inc. | FY2026 Q4 · Calendar Q4 2026 | +7.1% | -1.5% | Keysight’s record FY2026 sets up growth, with supply constraints still central |
| NTES NetEase, Inc. | FY2026 Q3 · Calendar Q4 2026 | -12.8% | -11.4% | NetEase’s game portfolio remains strong, while attention and monetization risks persist |
| PANW Palo Alto Networks, Inc. | FY2027 Q1 · Calendar Q4 2026 | +8.0% | +5.9% | Palo Alto Networks raises FY27 outlook as AI security demand accelerates |
Latest beats and misses
Who reports nextBeat on EPS
- INTUFY2027 Q1 · November 19, 2026+18.3% EPS-6.2% move
- ROSTFY2026 Q3 · November 19, 2026+2.1% EPS-2.8% move
- ESTCFY2027 Q2 · November 19, 2026+16.2% EPS+2.0% move
- KEYSFY2026 Q4 · November 19, 2026+7.1% EPS-1.5% move
- WSMFY2026 Q3 · November 19, 20260.0% EPS-15.2% move
- WMGFY2026 Q4 · November 19, 2026+50.9% EPS-0.6% move
Missed on EPS
- NTESFY2026 Q3 · November 19, 2026-12.8% EPS-11.4% move
- FUTUFY2026 Q3 · November 19, 2026-7.8% EPS+4.8% move
- BABAFY2027 Q2 · November 19, 2026-29.2% EPS-1.3% move
- SQMFY2026 Q3 · November 17, 2026-3.0% EPS-5.5% move
- VIKFY2026 Q3 · November 17, 2026-12.6% EPS+4.4% move
- XPFY2026 Q3 · November 16, 2026-3.0% EPS-2.5% move
Get the ZBRA recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-11-10T18:38:36.707185+00:00
- Polygon adjusted daily market bars · 2026-11-17T17:00:50.206475+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-17T17:00:50.204143+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-17. For educational purposes only; not investment advice.